SFGP
XTNT icon

Stonebridge Financial Group (Pennsylvania)’s Xtant Medical Holdings XTNT Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25
Closed -$12 – 970
2025
Q1 		$12 Hold
25
– – ﹤0.01% 1000
2024
Q4 		$11 Buy
+25
New +$12 ﹤0.01% 829

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s XTNT Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of Xtant Medical Holdings (XTNT) in Q2 2025, closing a stake of 25 shares — an estimated $12 sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in XTNT in Q4 2024 and held it in 2 quarters. The position peaked at $12 in Q1 2025. 30 funds tracked by Wall St. Rank hold XTNT as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining Xtant Medical Holdings position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 25 Xtant Medical Holdings shares in Q2 2025, an estimated $12.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Xtant Medical Holdings in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s Xtant Medical Holdings position peaked at $12 in Q1 2025.
  • 30 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.